Decision making criteria in oncology

M Glatzer, CM Panje, C Sirén, N Cihoric, PM Putora - Oncology, 2020 - karger.com
Decision making is one of the most complex skills required of an oncologist and is affected
by a broad range of parameters. For example, the wide variety of treatment options, with …

New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma

FY Fang, JS Rosenblum, WS Ho, JD Heiss - Cancers, 2022 - mdpi.com
Simple Summary Medulloblastoma is the most common pediatric brain tumor, comprising
one-third of all pediatric brain tumors, and originating in the posterior fossa of the brain. The …

X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice

P Montay-Gruel, A Bouchet, M Jaccard, D Patin… - Radiotherapy and …, 2018 - Elsevier
This study is the first proof of concept that the FLASH effect can be triggered by X-rays. Our
results show that a 10 Gy whole-brain irradiation delivered at ultra-high dose-rate with …

Neuroprotection of radiosensitive juvenile mice by ultra-high dose rate FLASH irradiation

Y Alaghband, SN Cheeks, BD Allen, P Montay-Gruel… - Cancers, 2020 - mdpi.com
Major advances in high precision treatment delivery and imaging have greatly improved the
tolerance of radiotherapy (RT); however, the selective sparing of normal tissue and the …

Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells

A Nellan, C Rota, R Majzner… - … for immunotherapy of …, 2018 - Springer
Background Standard-of-care therapies for treating pediatric medulloblastoma have long-
term side effects, even in children who are cured. One emerging modality of cancer therapy …

Medulloblastoma: optimizing care with a multidisciplinary approach

A Thomas, G Noël - Journal of multidisciplinary healthcare, 2019 - Taylor & Francis
Medulloblastoma is a malignant tumor of the cerebellum and the most frequent malignant
brain tumor in children. The standard of care consists of maximal resection surgery, followed …

Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination

V Martirosian, K Deshpande, H Zhou, K Shen, K Smith… - Cell reports, 2021 - cell.com
Medulloblastoma (MB) is a malignant pediatric brain tumor arising in the cerebellum.
Although abnormal GABAergic receptor activation has been described in MB, studies have …

Medulloblastoma: from molecular subgroups to molecular targeted therapies

J Wang, A Garancher, V Ramaswamy… - Annual review of …, 2018 - annualreviews.org
Brain tumors are the leading cause of cancer-related death in children, and
medulloblastoma (MB) is the most common malignant pediatric brain tumor. Advances in …

Adoptive immunotherapy using PRAME-specific T cells in medulloblastoma

D Orlando, E Miele, B De Angelis, M Guercio, I Boffa… - Cancer research, 2018 - AACR
Medulloblastoma is the most frequent malignant childhood brain tumor with a high morbidity.
Identification of new therapeutic targets would be instrumental in improving patient …

Autocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma

L Sreenivasan, H Wang, SQ Yap, P Leclair… - Cell Death & …, 2020 - nature.com
Medulloblastoma (MB) is a high-grade pediatric brain malignancy that originates from
neuronal precursors located in the posterior cranial fossa. In this study, we evaluated the …